
Opinion|Videos|July 10, 2024
ASCO 2024: Addressing Unmet Needs in Melanoma Treatment and Management
Key opinion leaders analyze unmet needs and emerging trends in melanoma treatment based on findings presented at ASCO 2024.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- Coming into ASCO 2024, what would did consider to be the largest unmet needs in the treatment and management of melanoma?
- What are the latest trends and innovations you have observed in the treatment and management of melanoma leading up to and coming out of ASCO 2024?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal
2
Network Disconnection, Not Lesion Volume, Drives MS Cognition
3
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
4
Colorblind Devices, Longer-Wavelength Lasers Offer Safer Options for Darker Skin Tones: Ariella Kauvar, MD
5